It is estimated that there are 11 million diabetics in the United States. Increasing recognition of the importance of nutrition in clinical medicine coupled with the frequent hospitalizations of the diabetic patient has heightened interest in their nutritional therapy. Patients with diabetes mellitus exhibit many abnormalities in the regulation of carbohydrate metabolism which may be accentuated during illness as part of the metabolic response to injury. An understanding of the effect of injury/illness, parenteral nutrition, and diabetes mellitus on carbohydrate metabolism is essential for the development of a rational approach to the initiation and maintenance of nutritional support in the diabetic patient. (Journal of Parenteral and Enteral Nutrition 13:545-553, 1989)
Get full access to this article
View all access options for this article.
References
1.
U.S. Department of Health & Human Services: Diabetes in America, Diabetes Data Compiled 1984-1985. U.S. Department of Health and Human Services, Washington, DC, NIH Pub. No. 85-468, 1986
2.
Klein R., Klein B.: Vision disorders in diabetes. IN Diabetes in America, National Diabetes Data Group. U.S. Departments of Health and Human Services, Washington, DC NIH Pub. No. 85-1468, 1985
3.
Herman W., Teutsch S.: Kidney diseases associated with diabetes. IN Diabetes in America, National Diabetes Data Group. U.S. Department of Health and Human Services, Washington, DC, NIH Pub. No. 85-1468, 1985
4.
Palumbo P., Melton L.: Peripheral vascular disease and diabetes. IN Diabetes in America, National Diabetes Data Group. U.S. Department of Health and Human Services, Washington, DC, NIH Pub. No. 85-1468, 1985
5.
Barrett-Connor E., Orchard T.: Diabetes and heart disease. In Diabetes in America, National Diabetes Data Group. U.S. Department of Health and Human Services, Washington, DC, NIH Pub. No. 85-1468, 1985
6.
Bistrian B., Blackburn G., Hallowell E., et al: Protein status of general surgical patients. JAMA230:858-860, 1974
7.
Bistrian B., Blackburn G., Vitale J., et al: Prevalence of malnutrition in general medical patients. JAMA235:1567-1570, 1976
8.
Dietz G., Wicklmayr M., Hepp K., et al: On gluconeogenesis of human liver: Accelerated hepatic glucose formation induced by increased precursor supply. Diabetologia12:555-561, 1976
9.
Nilsson L.: Liver glycogen content in man in the postabsorptive state. Scand J Clin lab Invest32:317-323, 1973
10.
Wahren J., Felig P., Ahlborg G., et al: Glucose metabolism during leg exercise in man. J Clin Invest50:2715-2725, 1971
11.
Shikama H., Ui M.: Glucose load diverts hepatic gluconeogenic product from glucose to glycogen in vivo. Am J Physiol235 :354-360, 1978
12.
Katz J., McGarry J.: The glucose paradox: Is glucose a substrate for liver metabolism? J Clin Invest74:1901-1909, 1984
13.
Scofield R. , Kosugi K., Schumann W., et al: Quantitative estimation of the pathways followed in the conversion to glycogen of glucose administered to the fasted rat. J Biol Chem260:8777-8782, 1985
14.
Buschiazzo H., Exton J., Park C.: Effects of glucose on glycogen synthetase, phosphorylase, and glycogen deposition in the perfused rat liver. Proc Natl Acad Sci USA65:383-387, 1970
15.
Bucolo R., Bergman R., Marsh D., et al: Dynamics of glucose autoregulation in the isolated, blood-perfused canine liver. Am J Physiol227:209-217, 1974
16.
Ruderman N. , Herrera M.: Glucose regulation of hepatic gluconeogenesis . Am J Physiol214:1346-1351, 1968
17.
Creutzfeld W.: The incretin concept today. Diabetologia16:75-85, 1979
18.
Rizza R., Mandarino L., Gerich J.: Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol240:E630-E639, 1981
19.
Verdonk C., Rizza R., Gerich J.: Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes30:535-537, 1981
20.
Cherrington A., Williams P., Harris M.: Relationship between the plasma glucose level and glucose uptake in the conscious dog. Metab Clin Exp27:787-791, 1978
Exton J., Park C.: The role of cyclic AMP in the control of liver metabolism. Adv Enzyme Regul6:391-407, 1968
23.
Long C., Smith O., Fry E.: Actions of cortisol and related compounds on carbohydrate and protein metabolism . IN Metabolic effects of adrenal hormone, Wolstenholm O, Connor M. (eds). Churchill, London, 1960
24.
Shulman G.; Glucose disposal during insulinopenia in somatostatin-treated dogs: The roles of glucose and glucagon. J Clin Invest62:487-492, 1978
25.
Porte D.: A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest46:86-94, 1967
26.
Rizza R., Cryer P., Haymond M., et al: Adrenergic mechanism for the effect of epinephrine on glucose production and clearance in man. J Clin Invest65:682-689, 1980
27.
Hers H.: The control of glycogen metabolism in the liver. Ann Rev Biochem45:167-189, 1976
28.
Walaas O., Walaas E.: Effect of epinephrine on rat diaphragm. J Biol Chem187:769-776, 1950
29.
Munck A.: Studies on the mode of action of glucocorticoids in rats. Biochem/Biophys Acta57:318-326, 1962
30.
Landsberg L. , Young J.: Fasting, feeding, and regulation of the sympathetic nervous system. N Eng J Med298:1295-1301, 1978
31.
Wood R., Bengoa J., Sitrin M., et al: Calciuretic effect of cyclic versus continuous total parenteral nutrition. Am J Clin Nutr41:614-619, 1985
32.
Benotti P., Bothe A., Miller J., et al: Cyclic hyperalimentation. Comprehensive Therapy . 2:27-36, 1976
33.
Rizza R., Mandarino L., Genest J., et al: Production of insulin resistance by hyperinsulinemia in man . Diabetologia28:70-75, 1985
34.
Maini B., Blackburn G., Bistrian B., et al: Cyclic hyperalimentation: An optimal technique for preservation of visceral protein. J Surg Res19:515-525, 1976
35.
Batstone G. , Alberti K., Hinks L., et al: Metabolic studies in subjects following thermal injury. Intermediary metabolites, hormones, and tissue oxygenation . Burns2:207-225, 1976
36.
Willerson J. , Hutcheson D., Leshin S., et al: Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency. Am J Med57:747-753, 1974
37.
Harris M., Cahill G., Bennett P., et al: National Diabetes Data Group. Diabetes28:1039-1057, 1979
38.
Wilmore D.: Carbohydrate metabolism in trauma. Clin Endocrinol Metab5:731-745, 1976
39.
Lindsey A., Santeusanio F., Braaten J., et al: Pancreatic alpha-cell function in trauma. JAMA227:757-761, 1974
40.
Christensen N., Jorgen V.: Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. J Clin Invest54:278-286, 1974
41.
Frankesson C., Gemzell C., VonEuler U.: Cortical and medullary adrenal activity in surgical and allied conditions. J Clin Endocrinol Metab14:608-621, 1954
42.
Eigler N., Sacca L., Sherwin R.: Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog. J Clin Invest63:114-123, 1981
43.
Shamoon M., Hendler R., Sherwin R.: Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab52:1235-1241, 1981
44.
Bessey P., Watters J., Aoki T., et al: Combined hormonal infusion stimulates the metabolic response to injury. Ann Surg200 :264-281, 1984
45.
McGarry J., Foster D.: Hormonal control of ketogenesis. Arch Intern Med137:495-501, 1977
46.
Dinarello C. : Interleukin-1. Rev Infect Dis6:51-95, 1984
47.
Dinarello C. , Mier J.: Interleukins. Ann Rev Med37:173-178, 1986
48.
Dinarello C. : LymphokinesN Engl J Med317:940-945, 1987
49.
Flores E., Pomposelli J., Bistrian B.: Interleukin-1. IN Protein and Peptides as Drugs, Ed. Nadler P (ed) Marcel Dekker, 1988
50.
Pomposelli J., Flores E., Bistrian B.: The role of biochemical mediators in clinical nutrition and surgical metabolism. JPEN12:20, 212-218, 1988
51.
Flores E., Istfan N., Pomposelli J., et al: Gluconeogenic-promoting effect of Interleukin-1, but not tumor necrosis factor/cachectin, during the acute phase response. Clin Res35:804A, 1987
52.
Wolfe R., Durkot M., Allsop J., et al: Glucose metabolism in severely burned patients. Metabolism28:1031-1039, 1979
53.
Wilmore D., Goodwin C., Aulick L., et al: Effect of injury and infection on visceral metabolism and circulation . Ann Surg192:491-582, 1980
54.
Beisel W., Wannemacher R.: Gluconeogenesis, ureagenesis, and ketogenesis during sepsis. JPEN4:277-285, 1980
55.
Guckian J.: Role of metabolism in pathogenesis of bacteremia due to diplococcus pneumoniae in rabbits. J Infect Dis127:1-8, 1973
56.
Canonico P. , White J., Powanda M.: Peroxisome depletion in rat liver during pneumococcal sepsis. Lab Invest33:14-1750, 1975
57.
Canonico P. , Rill W., Ayala E.: Effects of inflammation on peroxisomal enzyme activities, catalase synthesis, and lipid metabolism. Lab Invest37:479-486, 1977
58.
Wannemacher R., Neufeld M., Canonico P.: Hepatic gluconeogenic capacity and rate during pneumococcal infection in rats. Fed ProcA35:343, 1976
59.
Canonico P. , Ayala-Will W., Little J.: Effects of pneumococcal infection on rat liver microsomal enzymes and lipogenesis by isolated hepatocytes . Am J Clin Nutr30:1359-1363, 1977
60.
Moore R., Johnson B., Berry L.: Nutritional effects of salmonellosis in mice. Am J Clin Nutr30:1289-1293, 1977
61.
Pomposelli J., Flores E., Bistrian B., et al: Dose response of recombinant mediators in the acute phase response. Clin Res35(3):514A, 1987
62.
Bendtzen K. , Mandrup-Poulsen T., Nerup J., et al: Cytotoxicity of human pI7 interleukin-1 for pancreatic islets of Langerhans. Science232:1545-1547, 1986
63.
Wolfe R., O'Donnell T., Stone M., et al: Investigation of factors determining the optimal glucose infusion rate in total parenteral nutrition. Metabolism29:892-900, 1980
64.
Best J., Judzewitsch R., Pfeifer M., et al: The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin dependent diabetes. Diabetes31:333-338, 1982
65.
Revers R., Fink R., Griffin J., et al: Influence of hyperglycemia on insulin's in vivo effects in type II diabetes. J Clin Invest73 :664-672, 1984
66.
Forbath N., Hetenyi G.: Glucose dynamics in normal subjects and diabetic patients before and after a glucose load. Diabetes15 :778-789, 1966
67.
Bowen H., Moorhouse J.: Glucose turnover and disposal in maturity-onset diabetes. J Clin Invest52:3033-3045, 1973
68.
Kolterman O. , Gray R., Griffin J., et al: Receptor and postreceptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus . J Clin Invest68:957-965, 1981
69.
Rizza R., Mandarino L., Gerich J.: Mechanism and significance of insulin resistance in non-insulin dependent diabetes mellitus. Diabetes30:990-995, 1981
70.
Himsworth H. , Kerr R.: Insulin sensitive and insulin-insensitive types of diabetes mellitus. Clin Sci4:119-152, 1938
71.
DeFronzo R. , Diabert D., Hendler R., et al: Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest63:939-946, 1979
72.
Reaven G., Bernstein B., Davis B., et al: Non-ketotic diabetes mellitus: Insulin deficiency or insulin resistance? Am J Med60:80-88, 1976
73.
Firth R., Bell P., Marsh H., et al: Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. J Clin Invest77:1525-1532, 1986
74.
McMahon M., Rizza R.: The contribution of initial splanchnic glucose clearance and gluconeogenesis to postprandial hyperglycemia in noninsulin-dependent diabetes mellitus. Clin Res35:899A, 1987
75.
Bell P., Firth R., Rizza R.: Assessment of insulin action in insulin-dependent diabetes mellitus using [6-14C] glucose, [3-3H] glucose, and [2-3H] glucose. J Clin Invest78:1479-1486, 1986
76.
Shamoon H., Hendler R., Sherwin R.: Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetes. Diabetes29:284-291, 1980
77.
Shanbhogue R., Chwals W., Weintraub M., et al: Parenteral nutrition in the surgical patient. Br J Surg74:172-180, 1987
78.
Benotti P., Bistrian B.: Practical aspects and complications of total parenteral nutrition . Crit Care Clin3:115-131, 1987
79.
Driscoll D. , Bistrian B.: Clinical issues in the therapeutic monitoring of total parenteral nutrition. Clin Lab Med7:699-714, 1987
80.
Mascioli E. , Bistrian B.: TPN in the patient with diabetes . Nutr Support Serv3:12-16, 1983
81.
Padberg FT, Ruggiero J., Blackburn GL, et al: Central venous catherization for parenteral nutrition. Ann Surg193:264-270, 1981
82.
Weber S., Wood W., Jackson E.: Availability of insulin from parenteral nutrient solutions. Am J Hosp Pharm34:699-714, 1977
83.
Schernthaner G.: Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistance. Diabetes Care5(suppl 2):114-118, 1982
84.
Fireman P., Fineberg S., Galloway J.: Development of IgE antibodies to human (recombinant DNA), porcine and bovine insulins in diabetic subjects. Diabetes Care5(suppl 2):119-125, 1982
85.
Massi-Benedetti M., Burrin J., Capaldo B., et al: A comparative study of the activity of biosynthetic human insulin and portal insulin using the glucose clamp in normal subjects. Diabetes Care4:163-167, 1981
86.
Beyer J., Weber T., Schultz G., et al: Comparison of biosynthetic human insulin and pork insulin during rest, food ingestion, and physical work in insulin-dependent diabetic subjects using a glucose controlled insulin infusion system. Diabetes Care4:189-192, 1981
87.
Jensen GL, Seidner D., Mascioli E., et al: Fat emulsion infusion and reticuloendothelial system function in man. JPEN12:45, 1988
88.
Hamawy K., Moldawer L., Georgieff M., et al: Effect of lipid emulsions on the reticuloendothelial system function in the injured animal. JPEN9:559-565, 1985
89.
Nordenstrom J., Askanazi J., Elwyn D., et al: Nitrogen balance during total parenteral nutrition. Ann Surg197:27-33, 1983
90.
Miles J., Haymond M., Gerich J.: Suppression of glucose production and stimulation of insulin secretion of physiologic concentrations of ketone bodies in man. J Clin Endocrinol Metab52:34-37, 1981
91.
Marble A., White P., Fernald A.: The nature of the lowered resistance to infection in diabetes mellitus . J Clin Invest17:423-430, 1938
92.
Richardson R.: Immunity in diabetes. IV. Measurements of phagocytic activity in diabetes mellitus. Am J Med Sc204:29-35, 1942
93.
Bybee J., Roberts D.: The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. J Lab Clin Med64:1-13, 1964
94.
Crosby B., Allison F.: Phagocytic and bactericidal capacity of polymorphonuclear leucocytes recovered from venous blood of human beings. Proc Soc Exp Biol Med123:660-664, 1965
95.
Miller M., Baker L.: Leukocyte functions in juvenile diabetes mellitus: hormonal and cellular aspects . J Pediatr81:979-982, 1972
96.
Walters M., Lessler M., Stevenson T.: Oxidative metabolism of leukocytes from nondiabetic and diabetic patients . J Lab Clin Med78:158-166, 1971
97.
Bagdade J., Nielson K., Bulger R.: Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci263:451-456, 1972
98.
Bagdade J., Koot R., Bulger R.: Impaired leukocyte function in patients with poorly controlled diabetes . Diabetes293-15, 1974
99.
Tan J., Anderson J., Watanakunakorn C., et al: Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med85:26-33, 1975
100.
Neithammer D., Dieterle U., Kleihauer E., et al: An inherited defect in granulocyte function: impaired chemotaxis, phagocytosis, and intracellular killing of microorganisms. Helv Paediatr Acta30:537-541, 1975
101.
Okuda K., Takdokoro I., Noguchi Y.: Intraleukocytic bactericidal activity in patients receiving corticosteroid and radiation therapy, and in patients with diabetes mellitus. Jap J Microbiol19:97-103, 1975
102.
Jones R., Peterson C.: Hematologic alterations in diabetes mellitus. Am J Med70:339-352, 1981
103.
Bagdade J. , Stewart M., Walters E.: Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes27:677-681, 1978
104.
Mowat A., Baum J.: Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus . N Engl J Med284:621-27, 1971
105.
Hill H., Sauls H., Dettloff J., et al: Impaired leukocyte responsiveness in patients with juvenile diabetes mellitus. Clin Immunol Immunopathol2:395-403, 1974
106.
Nolan C., Beaty H., Bagdade J.: Impaired granulocyte bactericidal function in patients with poorly controlled diabetes. Diabetes. 27:889-894, 1978
107.
Repine J., Clawson C., Goetz F.: Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetes. J Infect Dis142:869-875, 1980
108.
Karnovsky M.: The metabolism of leukocytes. Semin Hemat5:156-165, 1968
109.
Munroe J., Shipp J: Glucose metabolism in leucocytes from patients with diabetes mellitus, with and without hypercholesterolemia. Diabetes14:584-590, 1965
110.
Cohn Z., Morse J.: Functional and metabolic properties of polymorphonuclear leucocytes . J Exp Med111:667-687, 1980
111.
Selvaraj R. , McRipley R., Sharva A.: The effect of phagocytosis and X-irradiation on human leukocyte metabolism. Cancer Res27:2280-2286, 1967
112.
DeFronzo R. , Sherwin R., Dillingham M., et al: Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. J Clin Invest61:472-479, 1978
113.
DeFronzo R. , Cooke C., Andres R., et al: The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest55:845-55, 1985
114.
Overett T. , Bistrian B., Lowry S., et al: Total parenteral nutrition in patients with insulin-requiring diabetes mellitus. J Am Coll Nutr5:79-89, 1986
115.
Sowers J., Tuck M., Sowers D.: Plasma antithrombin III and thrombin generation time: correlation with hemoglobin AIC and fasting serum glucose in young diabetic women. Diabetes Care3:655-8, 1980
116.
Banerjee R. , Salni A., Kumar V., et al: Antithrombin 3 deficiency in maturity onset diabetes mellitus and atherosclerosis. Throm Diath Haemmorh31:339-345, 1974
117.
Ceriello A. , Giugliano D., Quatraro A., et al: Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. Diabetes36:320-323, 1987
118.
Brownlee M. , Viassara H., Cerami A.: Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation : possible role in fibrin deposition in diabetics. Diabetes33:532-5, 1984
119.
Imperial J. , Bistrian B., Bothe A., et al: Limitation of central vein thrombosis in total parenteral nutrition by continuous infusion of low-dose heparin. J Am Coll Nutr2:63-73, 1983
120.
Fabri P., Mirtallo J., Ruberg R., et al: Incidence and prevention of thrombosis of the subclavian vein during total parenteral nutrition. Surg Gynecol Obstet155:238-240, 1982
121.
Newmark SR , Key JC, Roberts J.: Perioperative stabilization of glucose levels in patients supported with total parenteral nutrition. JPEN4:494-498, 1980
122.
Thompson JS , Chapin JW, Brown GL: Monitoring parenteral nutrition intraoperatively with the dextrometer. JPEN7:492-494, 1983
123.
Albert A., Takamatsu H., Fonkalsrud E.: Absorption of glucose solutions from the peritoneal cavity in rabbits . Arch Surg119:1247-1251, 1984
124.
Schade D., Eaton R., Friedman W., et al: Prolonged peritoneal infusion in a diabetic man. Diabetes Care3:314-317, 1980
125.
Irsigler K. , Kritz G., Hagmuler G., et al: Long-term continuous intraperitoneal insulin infusion with an implanted remote-controlled insulin infusion device . Diabetes30:1072-75, 1981
126.
Selam J., Slingeneyer A., Hedon B., et al: Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: Comparison with intravenous and subcutaneous routes. Diabetes Care6:105-111, 1983
127.
Schade D., Eaton R., Spencer W.: Normalization of plasma insulin profiles in diabetic subjects with programmed insulin delivery. Diabetes Care3:9-12, 1980
Rizza R., O'Brien P, Service F: Use of beef ultra-lente for basal insulin deliver: Plasma insulin concentrations after chronic ultra-lente administration in patients with IDDM. Diabetes Care9:120-123, 1986
